BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced today that it has appointed Jay M. Moyes, a 30-year veteran of the finance and biotechnology industries, as its chief financial officer.
